Calcitonin Salmon EP Impurity G is a structurally related peptide variant formed during calcitonin synthesis or oxidative degradation. Subtle residue modifications alter helix stability, disulfide geometry, and chromatographic mobility. Researchers investigate its conformational shifts to refine impurity-identification methods. Applications include peptide-stability studies, analytical specificity development, and structure-impurity correlation.
CAT No: Z10-101-188
Synonyms/Alias:[1,7-bis(3-sulfo-L-alanine)]calcitoninylglycine (salmon) (as per EP); [1,7-bis(3-sulfo-L-alanine)]calcitoninylglycine(salmon); Calcitonin (Salmon) EP Impurity G
Calcitonin Salmon EP Impurity G is a peptide compound structurally related to salmon calcitonin, a well-characterized hormone involved in calcium and bone metabolism. As an identified impurity according to the European Pharmacopoeia (EP) standards, this peptide fragment is of significant interest in the field of pharmaceutical quality control, peptide synthesis validation, and analytical method development. Its defined sequence and relation to the parent molecule make it a valuable reference material for researchers and industry professionals engaged in both regulatory compliance and the advancement of peptide-based therapeutics. The study and quantification of such impurities are critical for ensuring the safety, efficacy, and stability of peptide drug formulations.
Analytical Method Development: Calcitonin Salmon EP Impurity G is frequently utilized as a reference standard in the development and validation of analytical methods for peptide pharmaceuticals. Its presence enables researchers to calibrate chromatographic and spectrometric assays, such as HPLC or LC-MS, ensuring the reliable detection and quantification of impurities within salmon calcitonin preparations. By providing a well-characterized comparator, it facilitates the establishment of method specificity, accuracy, and sensitivity, which are essential parameters for robust quality control protocols.
Quality Control and Batch Release Testing: In the manufacturing of salmon calcitonin peptide drugs, the detection and quantification of known impurities like Impurity G are integral to batch release testing. Laboratories employ this peptide to assess the impurity profile of final products, verifying that levels remain within acceptable pharmacopoeial limits. Its use supports the documentation required for regulatory submissions and ongoing product monitoring, thereby helping to maintain consistent product quality and compliance with international standards.
Peptide Synthesis Process Validation: The presence of Calcitonin Salmon EP Impurity G can serve as an indicator of process-related byproducts or incomplete synthesis during the production of salmon calcitonin. By tracking the formation and persistence of this impurity in synthetic batches, researchers can optimize reaction conditions, improve purification strategies, and enhance overall process efficiency. This application is particularly valuable for contract manufacturers and research organizations focused on scaling up peptide production while minimizing unwanted side products.
Stability Studies: Reference peptides such as Impurity G are instrumental in forced degradation and stability testing protocols for peptide pharmaceuticals. By monitoring the generation and evolution of this impurity under various stress conditions, scientists gain insights into the degradation pathways and shelf-life attributes of salmon calcitonin formulations. Such studies inform formulation development, packaging decisions, and storage recommendations, contributing to the long-term integrity of peptide therapeutics.
Structural Characterization and Peptide Mapping: The defined sequence of Calcitonin Salmon EP Impurity G allows it to be employed in structural elucidation and peptide mapping studies. Researchers use this impurity as a benchmark to confirm the identity of peptides and to differentiate between structurally similar fragments in complex mixtures. Its inclusion in mapping protocols supports the comprehensive characterization of peptide drug substances, aiding in the identification of sequence variants, truncations, or modifications that may arise during synthesis or storage.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More